In Vitro Diagnostics (IVD) Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Coagulation), Manufacturer (Third party, OEM), End Users (Hospitals, Lab, Research) - Global Forecast to 2027
The global IVD quality control market is projected to reach USD 1.6 billion by 2027 from USD 1.3 billion in 2022, at a CAGR of 5.4% during the forecast period. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2019 and January 2023. Players in the global IVD Quality Control market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.
The product & service segment holds the highest share of the total IVD quality control market during the forecast period.
The quality control products segment accounted for the largest share of the IVD quality control market in 2021. The increasing number of accredited laboratories to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.
Serum/plasma-based controls segment accounted for the highest share for the Product and Services in total IVD quality control market during the forecast period.
Serum/plasma-based IVD quality controls are highly preferred by laboratories, as they are more stable after manipulation, such as freezing, storage, and lyophilization.; this segment accounted for the largest share of the quality control products market in 2021. The increasing number of IVD tests and the rising need for accuracy, reliability, and reproducibility of test results are the key factors driving the growth of the IVD quality control products market
Third-party controls dominated the Manufacturer segmented of IVD quality control market
Based on manufacturer, the IVD quality control market is segmented into OEM controls and third-party controls. The third-party controls segment accounted for the largest share of the manufacturer segment in the global IVD quality control market in 2021. The independent controls segment is expected to grow at the highest CAGR in the third-party controls market during the forecast period. The growth of this segment is attributed to the fact that regulatory bodies recommend independent controls.
During the forecast period, hospitals accounted for the highest share in the end users segment of the global IVD quality control market.
The end users of IVD quality controls included in this report are research & academic institutes, hospitals, clinical laboratories, and other end users (blood banks, local public health laboratories, home health agencies, and nursing homes). The hospitals segment accounted for the largest share of the IVD quality control market in 2021, and Clinical laboratories are estimated to be the fastest-growing end-user segment in this market. The increasing burden of infectious diseases across the globe and the growing volume of genetic testing are the key factors driving the growth of this end-user segment.
North America is will account for the highest share in the global IVD quality control market
By Region, the global IVD quality control market accounted in this report is divided into five major regions—North America, Europe, Latin America, the Asia Pacific, and the Middle East & Africa. In 2021, North America accounted for the largest share of the global IVD quality control market, followed by Europe. In North America, US accounted for the largest share folowed by Canada. The APAC region has the highest CAGR of the global IVD quality control market.
Key players in the IVD quality control Market
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
Break of primary participants was as mentioned below:
The market study covers the endoscopy equipment market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the IVD Quality Control market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
The product & service segment holds the highest share of the total IVD quality control market during the forecast period.
The quality control products segment accounted for the largest share of the IVD quality control market in 2021. The increasing number of accredited laboratories to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.
Serum/plasma-based controls segment accounted for the highest share for the Product and Services in total IVD quality control market during the forecast period.
Serum/plasma-based IVD quality controls are highly preferred by laboratories, as they are more stable after manipulation, such as freezing, storage, and lyophilization.; this segment accounted for the largest share of the quality control products market in 2021. The increasing number of IVD tests and the rising need for accuracy, reliability, and reproducibility of test results are the key factors driving the growth of the IVD quality control products market
Third-party controls dominated the Manufacturer segmented of IVD quality control market
Based on manufacturer, the IVD quality control market is segmented into OEM controls and third-party controls. The third-party controls segment accounted for the largest share of the manufacturer segment in the global IVD quality control market in 2021. The independent controls segment is expected to grow at the highest CAGR in the third-party controls market during the forecast period. The growth of this segment is attributed to the fact that regulatory bodies recommend independent controls.
During the forecast period, hospitals accounted for the highest share in the end users segment of the global IVD quality control market.
The end users of IVD quality controls included in this report are research & academic institutes, hospitals, clinical laboratories, and other end users (blood banks, local public health laboratories, home health agencies, and nursing homes). The hospitals segment accounted for the largest share of the IVD quality control market in 2021, and Clinical laboratories are estimated to be the fastest-growing end-user segment in this market. The increasing burden of infectious diseases across the globe and the growing volume of genetic testing are the key factors driving the growth of this end-user segment.
North America is will account for the highest share in the global IVD quality control market
By Region, the global IVD quality control market accounted in this report is divided into five major regions—North America, Europe, Latin America, the Asia Pacific, and the Middle East & Africa. In 2021, North America accounted for the largest share of the global IVD quality control market, followed by Europe. In North America, US accounted for the largest share folowed by Canada. The APAC region has the highest CAGR of the global IVD quality control market.
Key players in the IVD quality control Market
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
- By Designation – C-level–30%, Director-level–50%, Others–20%
- By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%
The market study covers the endoscopy equipment market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the IVD Quality Control market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 REFINEMENTS IN SEGMENTS OF GLOBAL IVD QUALITY CONTROLS MARKET
1.5.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
1.5.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
1.5.4 ADDITION OF RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC.
FIGURE 6 REVENUE ANALYSIS OF TOP FIVE COMPANIES: IVD QUALITY CONTROLS MARKET (2021)
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF IVD QUALITY CONTROLS MARKET (2022–2027)
FIGURE 8 CAGR PROJECTIONS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROLS MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 16 IVD QUALITY CONTROLS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IVD QUALITY CONTROLS MARKET
4 PREMIUM INSIGHTS
4.1 IVD QUALITY CONTROLS MARKET OVERVIEW
FIGURE 18 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET
4.2 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY AND COUNTRY (2021)
FIGURE 19 IMMUNOCHEMISTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.3 IVD QUALITY CONTROLS MARKET: REGIONAL MIX (2022–2027)
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 IVD QUALITY CONTROLS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH FROM 2022 TO 2027
4.5 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC MIX
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing number of accredited clinical laboratories
FIGURE 24 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (2022)
5.2.1.2 Growing adoption of third-party quality controls
5.2.1.3 Rising demand for external quality assessment support
5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases
TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)
FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
FIGURE 26 GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION)
5.2.1.5 Increasing adoption of POC instruments in developed regions
TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS
5.2.2 MARKET RESTRAINTS
5.2.2.1 Additional costs and budget constraints in hospitals and laboratories
5.2.2.2 Unfavorable reimbursement scenario for IVD tests
TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising demand for multianalyte controls
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS
5.2.4 MARKET CHALLENGES
5.2.4.1 Stringent product approval process
5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS
5.3 INDUSTRY TRENDS
5.3.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
5.3.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN
5.3.3 CONSOLIDATION OF LABORATORIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 29 IVD QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 10 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.1.2 Canada
TABLE 12 CANADA: CLASSIFICATION OF IVD PRODUCTS
TABLE 13 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.2 EUROPE
TABLE 14 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
TABLE 15 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
TABLE 16 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3.2 China
TABLE 17 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3.3 India
TABLE 18 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS
FIGURE 30 PATENT PUBLICATION TRENDS (2012–2022)
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO IVD QUALITY CONTROL
FIGURE 31 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD QUALITY CONTROL PATENTS (2012–2022)
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROLS MARKET
FIGURE 32 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROL (2012–2022)
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Analyte extraction
5.10.1.1.1 Specimen pooling
5.10.1.1.2 Human monoclonals
5.10.1.2 Specimen processing
5.10.1.2.1 Inactivation
5.10.1.2.2 Dilution
5.10.1.3 Preservation
5.10.2 ADJACENT TECHNOLOGIES
5.10.2.1 Sensor-based quality control
5.10.3 COMPLEMENTARY TECHNOLOGIES
5.10.3.1 Storage
5.10.3.2 Transport
5.10.3.3 Temperature control
5.10.3.4 Temperature monitoring
6 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE
6.1 INTRODUCTION
TABLE 19 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
6.2 QUALITY CONTROL PRODUCTS
TABLE 20 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 SERUM/PLASMA-BASED CONTROLS
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls
TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 23 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 WHOLE BLOOD-BASED CONTROLS
6.2.2.1 Rising need to ensure high-quality clinical test results to drive market
TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 25 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 URINE-BASED CONTROLS
6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls
TABLE 26 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 27 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 OTHER CONTROLS
TABLE 28 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 29 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 DATA MANAGEMENT SOLUTIONS
6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH
TABLE 30 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 31 IVD DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 QUALITY ASSURANCE SERVICES
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES
TABLE 32 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 33 IVD QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 34 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
7.2 IMMUNOCHEMISTRY
7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS
TABLE 35 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS
TABLE 36 IVD QUALITY CONTROLS MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 CLINICAL CHEMISTRY
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES PROVIDES OPPORTUNITIES FOR MARKET GROWTH
TABLE 37 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS
TABLE 38 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 MOLECULAR DIAGNOSTICS
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS
TABLE 39 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
TABLE 40 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 MICROBIOLOGY
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH
TABLE 41 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS
TABLE 42 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 HEMATOLOGY
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS
TABLE 43 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS
TABLE 44 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 COAGULATION AND HEMOSTASIS
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION AND HEMOSTASIS TESTING
TABLE 45 QUALITY CONTROLS FOR COAGULATION AND HEMOSTASIS OFFERED BY KEY MARKET PLAYERS
TABLE 46 IVD QUALITY CONTROLS MARKET FOR COAGULATION AND HEMOSTASIS, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 OTHER TECHNOLOGIES
TABLE 47 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS
TABLE 48 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE
8.1 INTRODUCTION
TABLE 49 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
8.2 THIRD-PARTY CONTROLS
TABLE 50 IVD THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 IVD THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 INDEPENDENT CONTROLS
8.2.1.1 Provide unbiased and independent performance assessment for analytical processes
TABLE 52 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 53 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 INSTRUMENT-SPECIFIC CONTROLS
8.2.2.1 Designed to evaluate and monitor performance of instruments
TABLE 54 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 55 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES
TABLE 56 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 57 IVD OEM CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9 IVD QUALITY CONTROLS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 58 IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HOSPITALS
9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET
TABLE 59 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 CLINICAL LABORATORIES
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET
TABLE 60 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 ACADEMIC AND RESEARCH INSTITUTES
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH
TABLE 61 IVD QUALITY CONTROLS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 OTHER END USERS
TABLE 62 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
10 IVD QUALITY CONTROLS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 63 IVD QUALITY CONTROLS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 64 IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT
10.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 65 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 US
10.2.2.1 High healthcare expenditure to propel market growth
TABLE 72 US: KEY MACROINDICATORS
TABLE 73 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 74 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 76 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 77 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Government initiatives to support market growth
TABLE 79 CANADA: KEY MACROINDICATORS
TABLE 80 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 81 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 83 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 84 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 86 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 88 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 90 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Rising volume of high-quality tests performed to support market growth
TABLE 93 GERMANY: KEY MACROINDICATORS
TABLE 94 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 95 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 97 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 98 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market
TABLE 100 FRANCE: KEY MACROINDICATORS
TABLE 101 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 102 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 104 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 105 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 UK
10.3.4.1 Growth in life sciences industry and increasing research to drive market
TABLE 107 UK: KEY MACROINDICATORS
TABLE 108 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 109 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 111 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 112 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis
TABLE 114 ITALY: KEY MACROINDICATORS
TABLE 115 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 116 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 118 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth
TABLE 121 SPAIN: KEY MACROINDICATORS
TABLE 122 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 123 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 125 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 126 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 RUSSIA
10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market
TABLE 128 RUSSIA: KEY MACROINDICATORS
TABLE 129 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 130 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 132 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 133 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.8 REST OF EUROPE
TABLE 135 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 136 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 138 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 139 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 34 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT
10.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market
TABLE 148 JAPAN: KEY MACROINDICATORS
TABLE 149 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 150 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 152 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 153 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Growing access to modern healthcare and government support to boost market growth
TABLE 155 CHINA: KEY MACROINDICATORS
TABLE 156 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 157 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 159 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls
FIGURE 35 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS, 2012–2022
TABLE 162 INDIA: KEY MACROINDICATORS
TABLE 163 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 164 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 166 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 167 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth
TABLE 169 AUSTRALIA: KEY MACROINDICATORS
TABLE 170 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 171 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 173 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 174 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market
TABLE 176 SOUTH KOREA: KEY MACROINDICATORS
TABLE 177 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 180 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 181 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 183 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 184 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 186 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 187 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 189 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 190 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 193 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 194 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Brazil dominates Latin American IVD quality controls market
TABLE 196 BRAZIL: KEY MACROINDICATORS
TABLE 197 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 198 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 200 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 201 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Increasing number of accredited clinical laboratories to support market growth
TABLE 203 MEXICO: KEY MACROINDICATORS
TABLE 204 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 205 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 207 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 208 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 210 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST AND AFRICA
10.6.1 MIDDLE EAST AND AFRICA: RECESSION IMPACT
10.6.2 RISING CANCER INCIDENCE TO DRIVE MARKET
TABLE 216 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 217 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 219 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 220 MIDDLE EAST AND AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 36 REVENUE ANALYSIS OF TOP PLAYERS IN IVD QUALITY CONTROLS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 37 IVD QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2021
11.5 COMPETITIVE BENCHMARKING
TABLE 222 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 223 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 224 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 225 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
11.6 REGIONAL FOOTPRINT OF KEY PLAYERS
TABLE 226 REGIONAL REVENUE MIX: IVD QUALITY CONTROLS MARKET
11.7 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS (2021)
11.8 R&D EXPENDITURE
FIGURE 39 IVD QUALITY CONTROLS MARKET: R&D EXPENDITURE (USD MILLION), 2021
11.9 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
11.9.1 PROGRESSIVE COMPANIES
11.9.2 DYNAMIC COMPANIES
11.9.3 STARTING BLOCKS
11.9.4 RESPONSIVE COMPANIES
FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2021)
11.10 COMPETITIVE SITUATIONS AND TRENDS
11.10.1 DEALS
TABLE 227 DEALS, JANUARY 2019–JANUARY 2023
11.10.2 PRODUCT LAUNCHES
TABLE 228 PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2023
11.10.3 OTHER DEVELOPMENTS
TABLE 229 OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2023
12 COMPANY PROFILES
(Business overview, Products and services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS
12.1.1 BIO-RAD LABORATORIES, INC.
TABLE 230 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.2 THERMO FISHER SCIENTIFIC, INC.
TABLE 231 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 42 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.3 RANDOX LABORATORIES LTD.
TABLE 232 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
12.1.4 LGC LIMITED
TABLE 233 LGC LIMITED: BUSINESS OVERVIEW
FIGURE 43 LGC LIMITED: COMPANY SNAPSHOT (2021)
12.1.5 ROCHE DIAGNOSTICS
TABLE 234 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 44 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
12.1.6 ABBOTT LABORATORIES
TABLE 235 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.7 SIEMENS HEALTHINEERS
TABLE 236 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 46 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
12.1.8 QUIDEL CORPORATION
TABLE 237 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 DANAHER CORPORATION
TABLE 238 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.10 SYSMEX CORPORATION
TABLE 239 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.11 ORTHO-CLINICAL DIAGNOSTICS, INC.
TABLE 240 ORTHO-CLINICAL DIAGNOSTICS, INC.: BUSINESS OVERVIEW
FIGURE 50 ORTHO-CLINICAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021)
12.1.12 BIO-TECHNE CORPORATION
TABLE 241 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 51 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021)
12.1.13 SEEGENE INC.
TABLE 242 SEEGENE INC.: BUSINESS OVERVIEW
FIGURE 52 SEEGENE INC.: COMPANY SNAPSHOT (2020)
12.1.14 QNOSTICS
TABLE 243 QNOSTICS: BUSINESS OVERVIEW
12.1.15 MICROBIOLOGICS, INC.
TABLE 244 MICROBIOLOGICS: BUSINESS OVERVIEW
12.1.16 ZEPTOMETRIX CORPORATION
TABLE 245 ZEPTOMETRIX CORPORATION: BUSINESS OVERVIEW
12.1.17 FORTRESS DIAGNOSTICS
TABLE 246 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
12.1.18 MICROBIX BIOSYSTEMS INC.
TABLE 247 MICROBIX BIOSYSTEMS INC.: BUSINESS OVERVIEW
FIGURE 53 MICROBIX BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.19 GRIFOLS, S.A.
TABLE 248 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 54 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
12.1.20 ALPHA-TEC SYSTEMS, INC.
TABLE 249 ALPHA-TEC SYSTEMS, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 HELENA LABORATORIES CORPORATION
TABLE 250 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
12.2.2 STRECK, INC.
TABLE 251 STRECK, INC.: BUSINESS OVERVIEW
12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC.
TABLE 252 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
12.2.4 SUN DIAGNOSTICS, LLC
TABLE 253 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
12.2.5 SERO AS
TABLE 254 SERO AS: BUSINESS OVERVIEW
*Details on Business overview, Products and services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 REFINEMENTS IN SEGMENTS OF GLOBAL IVD QUALITY CONTROLS MARKET
1.5.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
1.5.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
1.5.4 ADDITION OF RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC.
FIGURE 6 REVENUE ANALYSIS OF TOP FIVE COMPANIES: IVD QUALITY CONTROLS MARKET (2021)
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF IVD QUALITY CONTROLS MARKET (2022–2027)
FIGURE 8 CAGR PROJECTIONS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROLS MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 16 IVD QUALITY CONTROLS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IVD QUALITY CONTROLS MARKET
4 PREMIUM INSIGHTS
4.1 IVD QUALITY CONTROLS MARKET OVERVIEW
FIGURE 18 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET
4.2 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY AND COUNTRY (2021)
FIGURE 19 IMMUNOCHEMISTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.3 IVD QUALITY CONTROLS MARKET: REGIONAL MIX (2022–2027)
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 IVD QUALITY CONTROLS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH FROM 2022 TO 2027
4.5 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC MIX
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing number of accredited clinical laboratories
FIGURE 24 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (2022)
5.2.1.2 Growing adoption of third-party quality controls
5.2.1.3 Rising demand for external quality assessment support
5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases
TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)
FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
FIGURE 26 GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION)
5.2.1.5 Increasing adoption of POC instruments in developed regions
TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS
5.2.2 MARKET RESTRAINTS
5.2.2.1 Additional costs and budget constraints in hospitals and laboratories
5.2.2.2 Unfavorable reimbursement scenario for IVD tests
TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising demand for multianalyte controls
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS
5.2.4 MARKET CHALLENGES
5.2.4.1 Stringent product approval process
5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS
5.3 INDUSTRY TRENDS
5.3.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
5.3.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN
5.3.3 CONSOLIDATION OF LABORATORIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 29 IVD QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 10 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.1.2 Canada
TABLE 12 CANADA: CLASSIFICATION OF IVD PRODUCTS
TABLE 13 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.2 EUROPE
TABLE 14 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
TABLE 15 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
TABLE 16 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3.2 China
TABLE 17 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.8.3.3 India
TABLE 18 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS
FIGURE 30 PATENT PUBLICATION TRENDS (2012–2022)
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO IVD QUALITY CONTROL
FIGURE 31 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD QUALITY CONTROL PATENTS (2012–2022)
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROLS MARKET
FIGURE 32 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROL (2012–2022)
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Analyte extraction
5.10.1.1.1 Specimen pooling
5.10.1.1.2 Human monoclonals
5.10.1.2 Specimen processing
5.10.1.2.1 Inactivation
5.10.1.2.2 Dilution
5.10.1.3 Preservation
5.10.2 ADJACENT TECHNOLOGIES
5.10.2.1 Sensor-based quality control
5.10.3 COMPLEMENTARY TECHNOLOGIES
5.10.3.1 Storage
5.10.3.2 Transport
5.10.3.3 Temperature control
5.10.3.4 Temperature monitoring
6 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE
6.1 INTRODUCTION
TABLE 19 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
6.2 QUALITY CONTROL PRODUCTS
TABLE 20 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 SERUM/PLASMA-BASED CONTROLS
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls
TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 23 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 WHOLE BLOOD-BASED CONTROLS
6.2.2.1 Rising need to ensure high-quality clinical test results to drive market
TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 25 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 URINE-BASED CONTROLS
6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls
TABLE 26 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 27 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 OTHER CONTROLS
TABLE 28 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 29 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 DATA MANAGEMENT SOLUTIONS
6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH
TABLE 30 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 31 IVD DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 QUALITY ASSURANCE SERVICES
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES
TABLE 32 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 33 IVD QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 34 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
7.2 IMMUNOCHEMISTRY
7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS
TABLE 35 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS
TABLE 36 IVD QUALITY CONTROLS MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 CLINICAL CHEMISTRY
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES PROVIDES OPPORTUNITIES FOR MARKET GROWTH
TABLE 37 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS
TABLE 38 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 MOLECULAR DIAGNOSTICS
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS
TABLE 39 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
TABLE 40 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 MICROBIOLOGY
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH
TABLE 41 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS
TABLE 42 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 HEMATOLOGY
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS
TABLE 43 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS
TABLE 44 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 COAGULATION AND HEMOSTASIS
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION AND HEMOSTASIS TESTING
TABLE 45 QUALITY CONTROLS FOR COAGULATION AND HEMOSTASIS OFFERED BY KEY MARKET PLAYERS
TABLE 46 IVD QUALITY CONTROLS MARKET FOR COAGULATION AND HEMOSTASIS, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 OTHER TECHNOLOGIES
TABLE 47 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS
TABLE 48 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE
8.1 INTRODUCTION
TABLE 49 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
8.2 THIRD-PARTY CONTROLS
TABLE 50 IVD THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 IVD THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 INDEPENDENT CONTROLS
8.2.1.1 Provide unbiased and independent performance assessment for analytical processes
TABLE 52 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 53 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 INSTRUMENT-SPECIFIC CONTROLS
8.2.2.1 Designed to evaluate and monitor performance of instruments
TABLE 54 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 55 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES
TABLE 56 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 57 IVD OEM CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9 IVD QUALITY CONTROLS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 58 IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HOSPITALS
9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET
TABLE 59 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 CLINICAL LABORATORIES
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET
TABLE 60 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 ACADEMIC AND RESEARCH INSTITUTES
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH
TABLE 61 IVD QUALITY CONTROLS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 OTHER END USERS
TABLE 62 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
10 IVD QUALITY CONTROLS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 63 IVD QUALITY CONTROLS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 64 IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT
10.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 65 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 US
10.2.2.1 High healthcare expenditure to propel market growth
TABLE 72 US: KEY MACROINDICATORS
TABLE 73 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 74 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 76 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 77 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Government initiatives to support market growth
TABLE 79 CANADA: KEY MACROINDICATORS
TABLE 80 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 81 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 83 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 84 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 86 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 88 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 90 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Rising volume of high-quality tests performed to support market growth
TABLE 93 GERMANY: KEY MACROINDICATORS
TABLE 94 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 95 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 97 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 98 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market
TABLE 100 FRANCE: KEY MACROINDICATORS
TABLE 101 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 102 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 104 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 105 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 UK
10.3.4.1 Growth in life sciences industry and increasing research to drive market
TABLE 107 UK: KEY MACROINDICATORS
TABLE 108 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 109 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 111 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 112 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis
TABLE 114 ITALY: KEY MACROINDICATORS
TABLE 115 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 116 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 118 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth
TABLE 121 SPAIN: KEY MACROINDICATORS
TABLE 122 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 123 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 125 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 126 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 RUSSIA
10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market
TABLE 128 RUSSIA: KEY MACROINDICATORS
TABLE 129 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 130 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 132 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 133 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.8 REST OF EUROPE
TABLE 135 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 136 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 138 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 139 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 34 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT
10.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market
TABLE 148 JAPAN: KEY MACROINDICATORS
TABLE 149 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 150 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 152 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 153 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Growing access to modern healthcare and government support to boost market growth
TABLE 155 CHINA: KEY MACROINDICATORS
TABLE 156 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 157 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 159 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls
FIGURE 35 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS, 2012–2022
TABLE 162 INDIA: KEY MACROINDICATORS
TABLE 163 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 164 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 166 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 167 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth
TABLE 169 AUSTRALIA: KEY MACROINDICATORS
TABLE 170 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 171 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 173 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 174 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market
TABLE 176 SOUTH KOREA: KEY MACROINDICATORS
TABLE 177 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 180 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 181 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 183 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 184 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 186 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 187 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 189 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 190 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 193 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 194 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Brazil dominates Latin American IVD quality controls market
TABLE 196 BRAZIL: KEY MACROINDICATORS
TABLE 197 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 198 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 200 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 201 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Increasing number of accredited clinical laboratories to support market growth
TABLE 203 MEXICO: KEY MACROINDICATORS
TABLE 204 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 205 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 207 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 208 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 209 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 210 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 215 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST AND AFRICA
10.6.1 MIDDLE EAST AND AFRICA: RECESSION IMPACT
10.6.2 RISING CANCER INCIDENCE TO DRIVE MARKET
TABLE 216 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION)
TABLE 217 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 219 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION)
TABLE 220 MIDDLE EAST AND AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 36 REVENUE ANALYSIS OF TOP PLAYERS IN IVD QUALITY CONTROLS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 37 IVD QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2021
11.5 COMPETITIVE BENCHMARKING
TABLE 222 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 223 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 224 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
TABLE 225 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET
11.6 REGIONAL FOOTPRINT OF KEY PLAYERS
TABLE 226 REGIONAL REVENUE MIX: IVD QUALITY CONTROLS MARKET
11.7 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS (2021)
11.8 R&D EXPENDITURE
FIGURE 39 IVD QUALITY CONTROLS MARKET: R&D EXPENDITURE (USD MILLION), 2021
11.9 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
11.9.1 PROGRESSIVE COMPANIES
11.9.2 DYNAMIC COMPANIES
11.9.3 STARTING BLOCKS
11.9.4 RESPONSIVE COMPANIES
FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2021)
11.10 COMPETITIVE SITUATIONS AND TRENDS
11.10.1 DEALS
TABLE 227 DEALS, JANUARY 2019–JANUARY 2023
11.10.2 PRODUCT LAUNCHES
TABLE 228 PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2023
11.10.3 OTHER DEVELOPMENTS
TABLE 229 OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2023
12 COMPANY PROFILES
(Business overview, Products and services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS
12.1.1 BIO-RAD LABORATORIES, INC.
TABLE 230 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.2 THERMO FISHER SCIENTIFIC, INC.
TABLE 231 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 42 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
12.1.3 RANDOX LABORATORIES LTD.
TABLE 232 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
12.1.4 LGC LIMITED
TABLE 233 LGC LIMITED: BUSINESS OVERVIEW
FIGURE 43 LGC LIMITED: COMPANY SNAPSHOT (2021)
12.1.5 ROCHE DIAGNOSTICS
TABLE 234 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 44 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
12.1.6 ABBOTT LABORATORIES
TABLE 235 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.7 SIEMENS HEALTHINEERS
TABLE 236 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 46 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
12.1.8 QUIDEL CORPORATION
TABLE 237 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 DANAHER CORPORATION
TABLE 238 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.10 SYSMEX CORPORATION
TABLE 239 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.11 ORTHO-CLINICAL DIAGNOSTICS, INC.
TABLE 240 ORTHO-CLINICAL DIAGNOSTICS, INC.: BUSINESS OVERVIEW
FIGURE 50 ORTHO-CLINICAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021)
12.1.12 BIO-TECHNE CORPORATION
TABLE 241 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 51 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021)
12.1.13 SEEGENE INC.
TABLE 242 SEEGENE INC.: BUSINESS OVERVIEW
FIGURE 52 SEEGENE INC.: COMPANY SNAPSHOT (2020)
12.1.14 QNOSTICS
TABLE 243 QNOSTICS: BUSINESS OVERVIEW
12.1.15 MICROBIOLOGICS, INC.
TABLE 244 MICROBIOLOGICS: BUSINESS OVERVIEW
12.1.16 ZEPTOMETRIX CORPORATION
TABLE 245 ZEPTOMETRIX CORPORATION: BUSINESS OVERVIEW
12.1.17 FORTRESS DIAGNOSTICS
TABLE 246 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
12.1.18 MICROBIX BIOSYSTEMS INC.
TABLE 247 MICROBIX BIOSYSTEMS INC.: BUSINESS OVERVIEW
FIGURE 53 MICROBIX BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.19 GRIFOLS, S.A.
TABLE 248 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 54 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
12.1.20 ALPHA-TEC SYSTEMS, INC.
TABLE 249 ALPHA-TEC SYSTEMS, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 HELENA LABORATORIES CORPORATION
TABLE 250 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
12.2.2 STRECK, INC.
TABLE 251 STRECK, INC.: BUSINESS OVERVIEW
12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC.
TABLE 252 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
12.2.4 SUN DIAGNOSTICS, LLC
TABLE 253 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
12.2.5 SERO AS
TABLE 254 SERO AS: BUSINESS OVERVIEW
*Details on Business overview, Products and services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
